The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

Abstract Background Multi-matrix mesalazine (MMX) is an important treatment for ulcerative colitis (UC); however, it is often excreted intact, which increases the risk of relapse. This study aimed to clarify the risk factors for insoluble MMX excretion. Methods The subjects were 102 UC patients who...

Полное описание

Библиографические подробности

Главные авторы:	Ohtaki Yuichiro, Uchiyama Kan, Kamiya Hirotaka, Moriizumi Eri, Yamada Moe, Aoki Yuma, Watanabe Toshimune, Kiryu Sachie, Suzuki Sizuka, Matsumoto Yoshihiro, Ito Zensho, Ohkusa Toshifumi, Koido Shigeo, Saruta Masayuki
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2022-08-01
Серии:	BMC Gastroenterology
Предметы:	Ulcerative Colitis MMX Bristol Stool Form Scale 5-ASA Adherence Multi-matrix system mesalazine
Online-ссылка:	https://doi.org/10.1186/s12876-022-02474-9
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!